Clinical Research Directory
Browse clinical research sites, groups, and studies.
Glucose Control In Hematopoetic Stem Cell Transplant
Sponsor: University of Oklahoma
Summary
To determine whether intensive glucose control results in improved mortality and reduced hospital stay length by performing a randomized trial of intensive glucose management (blood glucose goal 110 mg/dl) using continuous IV insulin and glucose vs. non-intensive glucose management (goal 200 mg/dl)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
11
Start Date
2007-02
Completion Date
2009-05
Last Updated
2026-04-20
Healthy Volunteers
No
Interventions
Regular Insulin
Use of sliding scale insulin as per Appendix 1
Deployment of the MiniMed Paradigm monitoring device
Automated insulin delivery system
Locations (1)
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States